These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33860593)

  • 1. Implicating extracellular vesicles in Plasmodium falciparum artemisinin resistance development.
    Tandoh KZ; Wilson MD; Quashie NB; Duah-Quashie NO
    Traffic; 2021 Jun; 22(6):194-200. PubMed ID: 33860593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria artemisinin resistance: an extracellular vesicles export hypothesis.
    Tandoh KZ; Morang'a CM; Wilson M; Quashie NB; Duah-Quashie NO
    Trends Parasitol; 2022 Aug; 38(8):614-617. PubMed ID: 35661626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-module phenotype association study implicates extracellular vesicles biogenesis in
    Tandoh KZ; Hagan OC; Wilson MD; Quashie NB; Duah-Quashie NO
    Front Cell Infect Microbiol; 2022; 12():886728. PubMed ID: 36061874
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative stress changes the effectiveness of artemisinin in
    Pires CV; Cassandra D; Xu S; Laleu B; Burrows JN; Adams JH
    mBio; 2024 Mar; 15(3):e0316923. PubMed ID: 38323831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief history of artemisinin: Modes of action and mechanisms of resistance.
    Lu F; He XL; Richard C; Cao J
    Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin Action and Resistance in Plasmodium falciparum.
    Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
    Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
    van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
    Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial drugs resistance genes of Plasmodium falciparum: a review.
    Tchekounou C; Zida A; Zongo C; Soulama I; Sawadogo PM; Guiguemde KT; Sangaré I; Guiguemde RT; Traore Y
    Ann Parasitol; 2022; 68(2):215-225. PubMed ID: 35809349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Emergence of Plasmodium Resistance to Artemisinin Induced by the Use of Artemisia annua for Malaria and COVID-19 Prevention in Sub-African Region.
    Ataba E; Dorkenoo AM; Nguepou CT; Bakai T; Tchadjobo T; Kadzahlo KD; Yakpa K; Atcha-Oubou T
    Acta Parasitol; 2022 Mar; 67(1):55-60. PubMed ID: 34797496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 11. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
    Fairhurst RM; Nayyar GML; Breman JG; Hallett R; Vennerstrom JL; Duong S; Ringwald P; Wellems TE; Plowe CV; Dondorp AM
    Am J Trop Med Hyg; 2012 Aug; 87(2):231-241. PubMed ID: 22855752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How "resistant" is artemisinin resistant malaria? - The risks of ambiguity using the term "resistant" malaria.
    Hanscheid T; Hardisty DW
    Travel Med Infect Dis; 2018; 24():23-24. PubMed ID: 29715560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia.
    Dwivedi A; Reynes C; Kuehn A; Roche DB; Khim N; Hebrard M; Milanesi S; Rivals E; Frutos R; Menard D; Mamoun CB; Colinge J; Cornillot E
    Malar J; 2017 Dec; 16(1):493. PubMed ID: 29258508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Degradation Systems as Antimalarial Therapeutic Targets.
    Ng CL; Fidock DA; Bogyo M
    Trends Parasitol; 2017 Sep; 33(9):731-743. PubMed ID: 28688800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria outbreak in Laos caused by formerly rare artemisinin resistant strains of Plasmodium falciparum.
    Barry AE
    Lancet Infect Dis; 2023 May; 23(5):513-514. PubMed ID: 36462527
    [No Abstract]   [Full Text] [Related]  

  • 17. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.
    Cao P; Klonis N; Zaloumis S; Dogovski C; Xie SC; Saralamba S; White LJ; Fowkes FJI; Tilley L; Simpson JA; McCaw JM
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand.
    Woitsch B; Wernsdorfer G; Prajakwong S; Rojanawatsirivet C; Kollaritsch H; Wernsdorfer WH
    Wien Klin Wochenschr; 2004; 116 Suppl 4():35-40. PubMed ID: 15683041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application.
    Tun STT; Lubell Y; Dondorp AM; Fieldman T; Tun KM; Celhay O; Chan XH; Saralamba S; White LJ
    PLoS One; 2017; 12(5):e0177840. PubMed ID: 28531230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.